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Background: Placental production of corticotrophin releasing hormone (CRH) rises exponentially as pregnancy
progresses, and has been linked with the onset of normal and preterm labour. CRH is produced in
syncytiotrophoblast cells and production is increased by glucocorticoids and cAMP. It remains unclear whether
cAMP acts by inducing differentiation of cytotrophoblasts and/or through induction of syncytialisation. As CRH can
stimulate cAMP pathways we have tested whether a feed-forward system may exist in placental cells during
syncytialisation.
Methods: The choriocarcinoma BeWo cell line was treated with cAMP, CRH or vehicle. Cell viability was determined
by MTT assay, while apoptosis was analysed by DAPI staining and by FACS. Differentiation was measured by
assaying message for hCG and ERVW-1 (syncytin1) by qRT-PCR, as well as the respective protein by ELISA. Fusion of
BeWo cells was assessed by co-staining cell membrane and nuclei with CellMask and Hoechst 33342. CRHR1 and
CRHR2 mRNA levels were measured by qRT-PCR.
Results: We show that cAMP has an inductive effect on syncytialisation, as evidenced by induction of hCG
secretion, by ERVW-1 mRNA expression and by formation of multinuclear cells. CRH mRNA expression was found to
increase prior to the changes in the other syncytialisation markers. cAMP had an inhibitory effect on BeWo cell
viability, but exogenous CRH did not. However, CRH did mimic the differentiation inducing effect of cAMP,
suggesting a link between CRH and cAMP signalling in syncytialisation. We also found that treatment of BeWo cells
with exogenous CRH resulted in elevated cellular CRHR1 levels.
Conclusions: This study suggests a positive feed-forward role exists for CRH in trophoblast cell differentiation,
which may underlie the exponential rise in CRH observed as gestation advances.
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The differentiation of villous cytotrophoblast cells, the
main cellular component of the placenta, is critical for a
normal pregnancy as they mediate such steps as implant-
ation, pregnancy hormone production, immune protection
of the fetus, and delivery [1,2]. It is known that upon
in vitro stimulation with cAMP-inducing agents, such as
forskolin, cytotrophoblasts undergo fusion into syncytio-
trophoblasts. A syncytiotrophoblast is defined as a giant
cell with multiple nuclei sharing one cytoplasm, which
expresses certain markers including ERVW-1 (syncytin 1)
and human chorionic gonadotropin (hCG) [3,4]. The syn-
cytial mass, as assessed by the number of nuclei, in-
creases exponentially across gestation [5]. Many factors
are involved in the process of syncytialisation in the pla-
centa, including cAMP-dependent protein kinase A,
various protein tyrosine kinases, protein tyrosine phos-
phatases, ERVW-1, and GCM1 [4,6]. While the list of
players involved in cytotrophoblast differentiation is
rapidly growing, the mechanisms remain far from clear.
Corticotrophin releasing hormone (CRH), one of the
hypothalamic “stress” peptides, plays a pivotal role in mam-
malian survival and adaptation responses involving the
activation of the hypothalamic pituitary adrenal (HPA) axis.
Besides its presence in the central nervous system, CRH is
also expressed in the human placenta [7]. Placental CRH
becomes detectable in maternal plasma around 16~20 -
weeks gestation, and increases exponentially as pregnancy
progresses towards term. The level of placental CRH in
maternal circulation has been linked to the length of gesta-
tion [8-10]. Placental CRH appears to target multiple feto-
maternal tissues, including the foetal adrenals, myometrial
smooth muscle, placenta, placental vasculature and foetal
membranes [11-13]. Through the various CRH receptor
subtypes (CRHR1 and CRHR2) CRH plays diverse roles at
different stages of pregnancy and labour. For example,
CRH stimulates the foetal pituitary-adrenal axis, mo-
dulates placental vascular tone and endocrine function
(especially prostaglandin generation), controls myometrial
contractility ⁄ quiescence, and regulates trophoblast cell
growth and invasion [10]. Nevertheless, there is little
research literature available on a role for CRH in tropho-
blast cell differentiation.
We previously reported that stimulation by 8-Br-cAMP
of BeWo cells cultured in normal foetal calf serum
resulted in higher levels of hCG and ERVW-1 [14]. More-
over, other results from our laboratory have shown that
CRH promoter activity is increased by 8-Br-cAMP in
human placental cells [15], while others have shown
that CRH can act via CRH-receptors to stimulate GNAS
and increase cAMP production [16,17]. Therefore, in
this paper we investigated potential roles of CRH on the
viability and differentiation of human trophoblast BeWo
cells.Methods
Cell culture
The BeWo cell line, originally derived from a human
trophoblast choriocarcinoma, was from the American
Type Culture Collection. Cells were cultured in DMEM-
F12 (Cat. D2906, Sigma-Aldrich, St Louis, MO, USA)
supplemented with 10% foetal calf serum (FCS) (Cat.
12003C, SAFC Biosciences, Lenexa, Kansas, USA), L-
glutamine (200 mM), HEPES (25 mM), glucose (25 mM),
1×Antibiotic-Antimycotic (Cat. 15240, Invitrogen, Mount
Waverley, VIC, AU) and grown at 37°C in a 5% CO2 at-
mosphere. Once cells reached ~80% confluence they were
harvested with trypsin and transferred into new tissue
culture flasks with new media at a ratio of 1:3.
MTT assay
Cells were seeded at 4×104 cells per well in 24-well culture
plates in triplicate, and allowed to attach and stabilize for
24 h. The medium was then changed to 1 ml per well of
10% charcoal stripped FCS (CCS) media (Cat. 12676,
Invitrogen), followed by the administration of different
doses of 8-Br-cAMP (Cat. B7880, Sigma-Aldrich) or CRH
(C3042, Sigma-Aldrich) for a further 48 h. At indicated
times, the viable cells were determined by MTT assay.
Briefly, 100 μl of 5 mg/ml freshly made MTT solution was
added to the cell media and incubated for 3 h at 37°C and
dissolved with 750 μl DMSO. The absorbance at 570 nm
and 630 nm (as background optical density) was then mea-
sured using 96-well plates (150 μl/well) with a FLUOstar
OPTIMA microplate reader (BMG Labtech, Victoria,
Australia).
DAPI stain
Cells were seeded on coverslips pre-coated with 0.3% ge-
latine and set in 6-well plates at a density of 2 × 105/well.
The next day, cell culture media was changed to 10% CCS
(charcoal stripped FCS) media and the cells were treated
with 100 μM 8-Br-cAMP or 100 nM CRH for 72 h. Cells
were then fixed with 2% paraformaldehyde solution for
15 min and permeabilized with 0.2% Triton-X-100 for
10 min. After washing with PBS, the cells were incubated
with 2 μg/ml DAPI staining solution (0.1% Triton X-100,
2 mM MgCl2, 0.1 M NaCl, 100 mM 1,4-piperazine
diethane sulfonic acid, 1 μg/ml DAPI pH 6.8) for 5 min.
The slides were then washed, mounted and observed at
340–380 nm with Nikon Eclipse Ti fluorescent micro-
scope (Nikon TI-SR, JAPAN).
FACS analysis of apoptosis
BeWo cells were seeded in 6-well plates at a density of
2×105/well. The next day, the culture media was changed
to 10% CCS media with or without either 100 nM CRH or
100 μM 8-Br-cAMP for 72 hours. Cells were collected by
trypsin digestion and rinsed in 1x binding buffer, before
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the PE Annexin V Apoptosis Detection Kit I (Cat. 559763
BD Biosciences, San Diego, CA, USA). After a 30 min
incubation, samples were analysed by flow cytometry (BD
Biosciences) to determine the proportion of apoptotic cells.
Measurement of hCG secretion
BeWo cells were grown in 24-well plates, with the media
replenished once with 10% CCS 24 h after seeding. Cells
were then treated with 100 μM 8-Br-cAMP or 100 nM
CRH for 72 hours. The supernatant was collected and
kept at −80°C until assay, with the cell number deter-
mined by MTT assay. hCG quantification was conducted
with a hCG ELISA kit (Cat. #0400, Alpha Diagnostic
International, Texas, USA) according to the manufac-
turer’s instructions. The amount of hCG was normalized
by the corresponding cell number and expressed as the
fold of the untreated control.
Cell fusion assay
To visualize the formation of cell fusion, 2×105 BeWo
cells were grown on 19-mm coverslips set in 6-well plates,
and treated with either 100 μM 8-Br-cAMP or 100 nM
CRH in 10% CCS media and cultured for 72 h. These cells
were then incubated with 2 μg/ml CellMask Deep Red
plasma membrane stain (Cat. C10045, Invitrogen) at 37°C
for 5 min, followed by 5 μg/ml Hoechst 33342 (Cat.
H1399, Invitrogen) for 10 min. After rinsing 3 times with
PBS, cells were fixed with 4% paraformaldehyde for
15 min and mounted. Cell fusion was detected using a
confocal microscope, and cell fusion events were scored
when three or more nuclei shared the same cytoplasm, as
we described previously [14].
RT-quantitative PCR
Total RNA was extracted with RNeasy Mini kit (Cat.
#74106, Qiagen, Doncaster, VIC, AU) and 1 μg of total
RNA was used to synthesize first-strand cDNA using
a Superscript Ш First-strand kit (Cat. #18080-051,
Invitrogen), in accordance with the manufacturer’s in-
structions. qRT-PCR was performed using a 7500 real
time system (Applied Biosystems, Warrington, WA1
4SR, UK) and the SYBR GREEN PCR Master Mix (Cat.
4309155, Applied Biosystems). The PCR reaction volume
was 10 μl containing 2~3 μl of diluted cDNA and 0.2 μM
of each primer. PCR conditions were set as an initial poly-
merase activation step for 2 min at 95°C, followed by
40 cycles of 15 sec at 94°C for template denaturation,
15 sec at 60°C for annealing and 20 sec at 72°C for exten-
sion and fluorescence measurement. In addition, each
PCR reaction included a reverse transcription negative
control to check for potential genomic DNA contamin-
ation. Possible reagent contamination was controlled by
detection in a reaction mix without template. All sampleswere amplified in triplicates and the mean was used for
qRT-PCR analysis. The ΔΔCT method [18] was applied
to quantify the relative cDNA amount and ACTB was
used as internal control. The primers used were sense
50- GAAGGCCCTTCATAACCAATGA -30,antisense 50- G
ATATTTGGCTAAGGAGGTGATGTC -30 for ERVW-1
(83 bp), sense 50- CGGCATCGTCACCAACTG -30,anti-
sense 50- AAGGTGTGGTGCCAGATTTTCT -30 for AC
TB (51 bp). Sense 50-TCCCATCTCCCTGGATCTCAC-30,
antisense 50-GTGAGCTTGCTGTGCTAACTGCT-30 for
CRH (85 bp), sense 50- CGCATCCTCATGACCAAGCT -
30,antisense 50- TCACAGCCTTCCTGTACTGAATG -30
for CRHR1 (67 bp), sense 50- TGCGGAGCATTCGCTGT -
30,antisense 50- TTTCGCAGGATAAAGGTGGTG -30 for
CRHR2 (67 bp) [19].
Statistical analysis
All experiments were performed in triplicate and all
were repeated 3~5 independent times. The results are
expressed as mean ± SD and the differences between
groups were analysed using one-way ANOVA, with p <
0.05 being considered significant.
Results
Expression of mRNA for CRH and CRH receptors are
induced by cAMP
We have previously shown that 8-Br-cAMP increases
CRH promoter activity in human primary placental cells
[20]. In Figure 1 we show the effect of 8-Br-cAMP on
the expression of endogenous mRNA encoding compo-
nents of the CRH signalling pathway in BeWo cells.
BeWo cells were cultured in 10% Foetal Calf Serum
(FCS) media and treated with 0~1500 μM 8-Br-cAMP
for 48 h (Figure 1A) or 250 μM 8-Br-cAMP for 8~48 h
(Figure 1B), and the level of CRH mRNA was quantified
by qRT-PCR. Exposure to 8-Br-cAMP resulted in a
dose- and time- dependent increase in CRH mRNA; 2.2-
fold at 8 h and 8.6- fold at 48 h for the 250 μM treat-
ment (Figure 1A, B). We also found that the mRNA
levels for CRH receptors (CRHR1 and CRHR2) were also
stimulated by 8-Br-cAMP treatment in a dose dependent
manner (Figure 1C). Following exposure to 250 μM 8-
Br-cAMP, the increases of CRHR1 mRNA were ~2- fold
at 16 h and ~4- fold at 48 h, whereas CRHR2 mRNA ex-
pression was fairly constant from 16 h to 48 h, although
there is a ~2- fold increase observed compared to non-
treatment control (Figure 1D).
cAMP but not CRH stimulates apoptosis in BeWo cells
Previously published evidence has shown that BeWo cell
viability is decreased by forskolin through increased
cAMP [21], and that CRH can induce cell apoptosis in
several cell lines including the rat pheochromocytoma



























































































































































Figure 1 8-Br-cAMP induced CRH and CRHR mRNA expression in BeWo cells. BeWo cells were cultured in 10% CCS media and treated
without or with 100~1500 μM 8-Br-cAMP for 8~48 h, the expressions of CRH (A, B) CRHR1 and CRHR2 (C, D) mRNA were determined by
RT-quantitative PCR. Results shown are the induction fold relative to the control which was set at 1.0. Values are mean ± S.D. from 3 independent
experiments. * p<0.05, ** p<0.01.
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potential role of CRH on the cAMP-mediated effect on
cell survival of BeWo cells. We found that when BeWo
cells were treated with 100~750 μM 8-Br-cAMP for
48 h, there were more detached cells floating in the cul-
ture media compared to the control cells. MTT assay
showed that cell viability decreased with increasing dose
of 8-Br-cAMP (Figure 2A), with ~18% decrease in viabi-
lity at 100 μM 8-Br-cAMP and significantly less viability
(~39% decrease in viability at 750 μM) at higher doses of
8-Br-cAMP. In contrast, a 48 h incubation with 10~100
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Figure 2 Effect of 8-Br-cAMP and CRH on cell viability. BeWo cells wer
(A) or 0~100 nM CRH (B) for 48 h, and the viable cell number was determi
values plotted are mean ± S.D. * p<0.05, compared to control.cell number (~15% inhibition at 100 nM) without any
sign of cell death.
Based on these results, and because there is no signifi-
cant inhibition of cell viability, we chose 100 μM cAMP
and 100 nM CRH as the treatment dosage for further
experiments. Using DAPI staining, we investigated the
morphological changes in the nuclei of BeWo cells follow-
ing 8-Br-cAMP or CRH treatment. Figure 3A shows that
no apoptotic nuclei are apparent when BeWo cells are
cultured for 72 h with 100 nM CRH, whereas apoptotic
nuclei debris is clearly visible in cells cultured with 100 μM
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ned by MTT assay. All experiments were performed 4 times and the
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Figure 3 Effect of 8-Br-cAMP and CRH on cell apoptosis. BeWo cells were cultured in 10% CCS media and treated without or with 100 μM 8-
Br-cAMP or 100 nM CRH for 72 h. (A) DAPI stain of apoptotic nuclei. Cells were fixed and nuclear morphology were observed by staining with
DAPI and visualized by fluorescence microscopy (20×). Data shown are representative results from 3 independent experiments. Arrows shown are
the condensed nuclei or nuclear fragments described in the text. (B) FACS analysis of apoptotic portion. Cells were collected, stained by Annexin
V/7-ADD and measured by flow cytometry. Data shown is representative of FACS analysis. (C) Statistic analysis of apoptotic cells based on
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Figure 4 CRH induced CRHR mRNA expression in BeWo cells.
BeWo cells were cultured in 10% CCS media and treated without or
with 10~500 nM CRH for 48 h, the expressions of CRHR1 and CRHR2
mRNA were determined by RT-quantitative PCR. Results shown are
the induction fold relative to the control which was set at 1.0. Values
are mean ± S.D. from 3 independent experiments. * p<0.05,
** p<0.01.
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significantly increased by 72 h of 100 μM cAMP treatment
(16.40±1.14) as compared to the control (11.81±1.36).
However, there was no change between the control and
100 nM CRH treatment samples (Figure 3B, C).
CRH up-regulates CRHR1 and CRHR2 mRNA expression
Since CRH receptors are crucial in mediating CRH bio-
activities, the lack of cell apoptosis in response to CRH
prompted us to examine whether down-regulation of
CRH receptors was occurring due to extended CRH ex-
posure. In Figure 4, BeWo cells were treated with 0~500
nM CRH for 48 h in 10% charcoal stripped FCS (CCS)
media, and the levels of CRHR1 and CRHR2 mRNA
were quantified by qRT-PCR. We observed that CRH
up-regulated the expression of both CRHR1 and CRHR2
in a dose dependent manner. Although 10 nM CRH had
no significant effect on the expression of the CRH recep-
tors, CRHR1 mRNA expression increased by 1.8-fold at
100 nM and approximately 2-fold at 500 nM CRH treat-
ment. Similarly, CRHR2 increased by about 2-fold and
2.8-fold at 100 nM and 500 nM CRH respectively
(Figure 4). This indicates that the CRH signalling path-
way is intact and that the potential for a positive feed-
forward pathway exists in BeWo cells.
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8-Br-cAMP and CRH
As cAMP is a key component of the signalling pathway
that promotes cytotrophoblast cell fusion, we queried
whether CRH has any effect on advancing BeWo cell
differentiation. The effects of 8-Br-cAMP and CRH on
the molecular markers of cytotrophoblast differentiation,
ERVW-1 mRNA expression (Figure 5A, B) and hCG se-
cretion (Figure 6A, B), were determined by qRT-PCR
and ELISA assay respectively. 8-Br-cAMP treatment had
no detectable effect on the expression of ERVW-1 within
24 h (data not shown), but at 48 hours following 50 or
100 μM 8-Br-cAMP treatment ERVW-1 mRNA expres-
sion was induced by 3.04- and 3.4- fold (Figure 5A). 10
nM CRH did not induce ERVW-1 mRNA expression
while 100 nM CRH increased it by 1.87- fold (Figure 5B).
As determined by ELISA, hCG secreted into the culture
media increased by 4.4- and 8.0- fold (Figure 6A) when
BeWo cells were treated with 50 or 100 μM 8-Br-cAMP
treatment for 72 h respectively. However, 10~100 nM
CRH had no effect on hCG secretion (Figure 6B). Fusion
of BeWo cells was assessed by co-staining cell mem-
brane and nuclei with CellMask and Hoechst 33342. Cell
fusion, as defined by the presence of multinucleated cells,
was seldom seen in control cells, but multinucleated cells
containing more than four nuclei could always be seen in
cell cultures treated with either 100 μM cAMP or 100 nM
CRH for 72 h (Figure 7). This indicates that both cAMP
and CRH are effective in promoting cytotrophoblast cell
differentiation.
Discussion
CRH is known to activate the cAMP/PKA (protein
kinase A) pathway via its receptors, CRHR1 and CRHR2,
leading to phosphorylation of the cAMP response elem-
ent binding protein (CREB1) [25]. As a transcription
factor, CREB1 binds to a cAMP response element (CRE)







































Figure 5 Effect of 8-Br-cAMP and CRH on ERVW-1 mRNA expression. B
without 50~100 μM 8-Br-cAMP (A) or 10~100 nM CRH (B) for 48 h, the exp
Results shown are the induction fold relative to the control which was set
* p<0.05.transcription of those genes [26,27]. CRH has been stud-
ied as one of those target genes containing a CRE in the
promoter, and the CRE has been shown to be crucial for
CRH gene expression [28-30]. Furthermore, CRH and its
receptors (CRHR1/R2) are expressed in placental tissues
[9,31] and CRH can bind to syncytiotrophoblast mem-
branes [32]. So, the induction of CRH by cAMP hints
that CRH may play a feedback role in cAMP mediated
effects in placental trophoblasts.
Using BeWo choriocarcinoma cells as a well-established
cellular model of placental trophoblast syncytialisation we
showed that, in the presence of serum, 8-Br-cAMP signifi-
cantly induces cell apoptosis and promotes differentiation.
Our previous data also revealed that 8-Br-cAMP had less
effect on BeWo cell viability and syncytialisation if cells
were cultured in 10% charcoal stripped media [14], since
charcoal stripping would remove other factors such as ste-
roids, leading us to imply that CRH signal pathways may
play a role in cAMP-mediated cell apoptosis and differen-
tiation. The ability of CRH to regulate cell apoptosis in
several cells of different origin has been reported [33,34],
and CRH has been shown to induce FASLG (Fas ligand)
production and apoptosis in the rat pheochromocytoma
cell line PC12 via activation of MAPK (p38 mitogen-
activated protein kinase) [22]. This prompted us to further
propose that although CRH is produced by differentiated
trophoblasts it may also play a role in regulating tropho-
blast viability, thereby helping to keep the syncytio-
trophoblast pool in renewal. However, our experiments
reveal that although CRH induces cell apoptosis in some
cell lines it has no significant effect on BeWo cell viability,
according to DAPI stain and FACS analysis. This also sug-
gests that any effect that 8-Br-cAMP has on BeWo cell
viability is mediated through a signal pathway other than a
CRH pathway. Indeed, these results indicate that while
CRH may activate GNAS pathways, cAMP may activate
additional compartments of cAMP mediated signalling, or
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eWo cells were cultured in 10% CCS media and treated with or
ression of ERVW-1 mRNA was determined by RT-quantitative PCR.


































































Dose of CRH (nM) 
BA
Figure 6 Effect of 8-Br-cAMP and CRH on hCG secretion. BeWo cells were cultured in 10% CCS media and treated with or without
50~100 μM 8-Br-cAMP (A) or 10~100 nM CRH (B) for 72 h. The amount of hCG in the media was measured by ELISA assay. The respective cell
number was determined by MTT assay. The relative amount of hCG secretion was normalized by the cell number. Results shown are the
induction fold relative to the control which was set at 1.0. Values are mean ± S.D. from 3 independent experiments. * p<0.05.
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existence of CRH receptors in BeWo cells suggests that
CRH could be involved in another bioactivity, such as
modulation of differentiation or syncytialisation of tropho-
blast cells. Consistent with this idea, we demonstrated that
CRH can induce cell differentiation, as evidenced by the
induction of ERVW-1 and by cell fusion. For trophoblast
cells, the widely accepted marker of differentiation is a
combination of a biochemical index (induction of hCG
and ERVW-1 proteins) and a morphological index (forma-
tion of cell fusion), with the latter being more convincing.
Recently, the reliability of hCG as a trophoblast differen-
tiation marker has been called into question, due to dis-
sociation of the two differentiation indexes. We show here
additional evidence that biochemical and morphological
differentiation can be dissociated, since CRH facilitates
cell fusion without any induction of hCG secretion. Also,
in primary human trophoblasts, CRH stimulation induced
ERVW-1 expression, without any induction of hCG se-
cretion [35]. Similar dissociations have been reported in
villous cytotrophoblast cells cultured in the absence of
serum [36] and in JEG3 cells stimulated by forskolin,
where an induction of hCG occurred without any
evidence of cell fusion [21]. Recently, it was reported thatCon 72h 100 nM CR
Figure 7 Effect of 8-Br-cAMP and CRH on cell fusion in BeWo cells. Be
or with 100 nM CRH or 100 μM 8-Br-cAMP for 72 h. Cells were stained with
stain (blue), and visualized by confocal microscope (100×). Arrows indicate
independent experiments.the PKA inhibitor, H89, can reverse forskolin-induced
BeWo cell fusion without altering forskolin-induced hCG
secretion [37]. Therefore, hCG protein expression may
not necessarily be linked to syncytial fusion. This study
adds to the growing evidence that differentiation and
fusion are related but distinct events [38]. However, the
secretion of hCG can be enhanced by 8-Br-cAMP but not
by CRH, suggesting that CRH and 8-Br-cAMP may re-
gulate cell fusion through different signal pathways.
Indeed, others have shown that charcoal scavenged hor-
mones, such as estradiol, glucocorticoids and hCG, play
roles in trophoblast differentiation at different stages of
pregnancy [39].
We recently published evidence of a coherent relation-
ship between the induction by cAMP of apoptosis and
syncytial differentiation in BeWo cells. In cells cultured
in media containing serum, a large increase in FASLG/
FAS ratio and the occurrence of cell apoptosis coincided
with a greater induction of ERVW-1 and hCG and the
formation of syncytia. In contrast, in cells cultured in
media lacking serum, the lower increase in FASLG/FAS
ratio with no apparent cell apoptosis is in agreement
with the lower induction of ERVW-1 and hCG with no
sign of cell fusion [14]. This relationship has promptedH 72h 100 M cAMP 72h 
Wo cells were cultured in 10% CCS media and treated without (Con)
CellMask plasma membrane stain (red) and Hochest 33342 nuclear
position of syncytium. The results are representative of 3
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process involves an apoptotic event. Clearly, the data in
this paper shows that 8-Br-cAMP induces both cell
apoptosis as well as cell fusion whereas CRH has no
effect on apoptosis but can still promote cell fusion, in-
dicating that syncytialisation is a process that can occur
either with or without cell apoptosis. 8-Br-cAMP and
CRH both elevate intracellular cAMP, with 8-BR-cAMP
resulting in a sustained intracellular cAMP elevation
resistant to phosphodiesterases, whereas elevations via
cAMP are transient and compartmentalized and, as in
other studies, this could determine whether elevating
cAMP is pro- or anti- apoptotic [40]. Thus, whether the
syncytialisation process correlates with an apoptosis pro-
gram or not is far more complex than previously realised,
and may depend on either, or both, the inducer and the
cell model used. Furthermore, we found that the expre-
ssion of CRHR1 and CRHR2 can be up regulated by 8-
Br-cAMP and also by CRH itself. This latter finding allows
the possibility that CRH and the CRH-receptors are in-
volved in a positive feed-forward system that may underlie
the exponential rise in CRH observed across pregnancy
that leads to delivery. This requires further investigation
but, if correct, suggests the timing of birth in humans is
an event determined by a placental maturation program.Conclusions
Our data provides, for the first time, evidence that there
may exist a positive feed-forward mechanism in the CRH/
CRHR/cAMP/PKA/CREB1 signal pathway, and that this
occurs at several different levels. The positive communica-
tion existing with CRH and its receptors has the potential
to magnify CRH bioactivities by, for example, promotion of
trophoblast cell syncytialisation. Since placental CRH ex-
pression in trophoblast cells begins when the cells differen-
tiate toward syncytialisation, the positive feed-forward and
promotion of syncytialisation by CRH could explain the ex-
ponential increase of CRH detected in maternal plasma as
pregnancy progresses towards term, particularly as syncytial
nuclear numbers increase exponentially across gestation
[5]. This may provide the mechanism that links maturation
of the placental structure to the timing of birth.Abbreviations
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